Fig. 7

Experimental validation of YCF active compounds and related pathways. A Protein expression levels (measured by western blot) of p-P38, P38, p-P65, P65, p-mTOR, mTOR, and GAPDH in M1 macrophages after treatment with different concentrations of YCF5. B Protein expression levels of p-P38, P38, p-P65, P65, p-mTOR, mTOR, and GAPDH in M1 macrophages after treatment with different concentrations of Ginsenoside Rg3. C Protein expression levels of p-P38, P38, p-P65, P65, p-mTOR, mTOR, and GAPDH in M1 macrophages after treatment with different concentrations of Ginsenoside RD. D Protein expression levels of p-P38, P38, p-P65, P65, p-mTOR, mTOR, and GAPDH in M1 macrophages after treatment with different concentrations of Cucurbitacin D. All data are presented as the mean ± SD (n = 3). ^#p < 0.05, ^##p < 0.01 vs. Control group; ^*p < 0.05, ^**p < 0.01 vs. Model group